CRNX is delisted effective immediately. All outstanding shares have been converted to cash; no further trading or equity positions exist. Monitor for any residual payments or claims processing, but the transaction is closed.
Price Chart
Executive Summary
Nasdaq has filed Form 25 to delist Crinetics Pharmaceuticals (CRNX) common stock effective September 1, 2026, following the closing of the all-cash acquisition by Vertex Pharmaceuticals at $85.00 per share, with aggregate consideration of approximately $10.0 billion. The delisting is the final procedural step in the merger; the stock will no longer trade.
Key Facts
- Form 25-NSE filed by Nasdaq to remove CRNX from listing and registration effective September 1, 2026.
- Delisting follows the completion of the all-cash merger with Vertex Pharmaceuticals, where each CRNX share was converted into $85.00 in cash.
- Aggregate merger consideration was approximately $10.0 billion.
Financial Impact
Shareholders received $85.00 per share in cash, representing a fixed premium; no further equity value remains.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0001354457-26-000839 |
| Document: 0001354457-26-000839-index-headers.html | 0001354457-26-000839 |
| Document: 0001354457-26-000839-index.html | 0001354457-26-000839 |
| Document: 0001354457-26-000839.txt | 0001354457-26-000839 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | 15-12G | — | awaiting T+1 | — | — |
Sep 1, 2026 4w ago | 25-NSE | $84.95 $84.95 | · 0.00% | ▼ −0.44% | — |
Sep 1, 2026 4w ago | 8-K | $84.95 $84.95 | · 0.00% | ▼ −0.44% | — |
Aug 14, 2026 7w ago | 8-K | $84.70 $84.75 | ▲ +0.06% | ▲ +0.53% | — |
Aug 3, 2026 8w ago | Press Release | $83.86 $84.00 | ▲ +0.17% | ▲ +0.37% | — |
Jul 10, 2026 12w ago | DEFA14A | $83.67 $83.71 | ▲ +0.05% | ▼ −0.31% | — |
Jul 10, 2026 12w ago | 8-K | $83.67 $83.71 | ▲ +0.05% | ▼ −0.31% | — |
Jun 30, 2026 13w ago | Press Release | $38.68 $42.23 | ▲ +9.18% | ▲ +9.31% | — |
Jun 14, 2026 15w ago | Press Release | $35.12 $35.00 | ▼ −0.34% | ▲ +0.25% | — |
Jun 14, 2026 15w ago | Press Release | $35.12 $35.00 | ▼ −0.34% | ▲ +0.25% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access